Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. (SHE:301290)

SHE:301290 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	398.19	430.47	430.5	440.73	442.57	354.91
Other Revenue	4.99	4.99	3.23	1.37	3.93	19.52
Revenue	403.18	435.46	433.73	442.1	446.5	374.43
Revenue Growth (YoY)	-8.08%	0.40%	-1.89%	-0.98%	19.25%	26.67%
Cost of Revenue	206.66	221.08	225.86	210.6	195.33	167.82
Gross Profit	196.52	214.38	207.88	231.5	251.17	206.61
Selling, General & Admin	106.67	112.72	106.62	93.08	104.58	91.48
Research & Development	18.84	22.43	27.11	24.21	20.67	18.32
Other Operating Expenses	14.79	5.18	2.65	4.39	3.14	4.19
Operating Expenses	138.05	140.77	135.94	124.56	128.17	112.8
Operating Income	58.47	73.6	71.94	106.94	123	93.82
Interest Expense	-1	-0.34	-0.06	-0.13	-0.11	-2.3
Interest & Investment Income	28.11	39.4	16.25	5.28	2.4	1.18
Currency Exchange Gain (Loss)	-0.14	-0.14	-0.02	0.49	-0.1	-0.15
Other Non Operating Income (Expenses)	0.35	-0.1	-0.05	-0.28	-0.34	-0.3
EBT Excluding Unusual Items	85.78	112.42	88.05	112.3	124.85	92.25
Gain (Loss) on Sale of Investments	1.12	-7	13.69	0.5	-	-
Gain (Loss) on Sale of Assets	-0.09	-0.09	-0.59	-0.43	-0.25	-0.13
Asset Writedown	-103.96	-	-	-	-	-
Other Unusual Items	11.1	9.73	15.91	7.44	5.33	3.51
Pretax Income	-6.04	115.06	117.06	119.82	129.93	95.63
Income Tax Expense	16.04	18.17	17.18	16.1	18.86	15.35
Earnings From Continuing Operations	-22.08	96.89	99.88	103.72	111.07	80.28
Minority Interest in Earnings	0.72	0.53	-2.66	-1.21	-0.82	-0.57
Net Income	-21.36	97.42	97.22	102.51	110.25	79.7
Net Income to Common	-21.36	97.42	97.22	102.51	110.25	79.7
Net Income Growth	-	0.21%	-5.15%	-7.03%	38.33%	68.22%
Shares Outstanding (Basic)	100	99	100	77	75	68
Shares Outstanding (Diluted)	100	99	100	77	75	68
Shares Change (YoY)	0.87%	-0.81%	30.05%	2.76%	10.45%	25.21%
EPS (Basic)	-0.21	0.98	0.97	1.33	1.47	1.17
EPS (Diluted)	-0.21	0.98	0.97	1.33	1.47	1.17
EPS Growth	-	1.03%	-27.07%	-9.52%	25.64%	34.48%
Free Cash Flow	31.08	10.54	51.68	20.28	67.78	88.64
Free Cash Flow Per Share	0.31	0.11	0.52	0.26	0.90	1.30
Dividend Per Share	0.600	0.600	0.600	0.500	-	-
Dividend Growth	-	-	20.00%	-	-	-
Gross Margin	48.74%	49.23%	47.93%	52.36%	56.25%	55.18%
Operating Margin	14.50%	16.90%	16.59%	24.19%	27.55%	25.06%
Profit Margin	-5.30%	22.37%	22.41%	23.19%	24.69%	21.29%
Free Cash Flow Margin	7.71%	2.42%	11.91%	4.59%	15.18%	23.67%
EBITDA	103.22	115.31	109.58	141.18	150.64	117.07
EBITDA Margin	25.60%	26.48%	25.26%	31.93%	33.74%	31.27%
D&A For EBITDA	44.76	41.71	37.64	34.24	27.64	23.26
EBIT	58.47	73.6	71.94	106.94	123	93.82
EBIT Margin	14.50%	16.90%	16.59%	24.19%	27.55%	25.06%
Effective Tax Rate	-	15.79%	14.68%	13.44%	14.52%	16.05%
Revenue as Reported	403.18	435.46	433.73	442.1	446.5	374.43
Advertising Expenses	-	2.07	1.87	1.34	2.48	1.85

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.